ATOS H. Lawrence Remmel buys $7K worth of shares
Mar 29, 2025, 4:36 AM
0.00%
What does ATOS do
Atossa Therapeutics, based in Seattle, focuses on developing oral (Z)-endoxifen for breast cancer treatment and prevention, having completed four Phase I and two Phase II clinical studies. The company went public on November 8, 2012, and employs 10 people.
H. Lawrence Remmel bought 10,000 shares of ATOS on 26 March at $0.70 per share, worth a total of $7K. They now own 10,257 ATOS shares, or a 3891% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.